World Top 10 Pediatric Healthcare Market – Opportunities and Forecasts, 2014 – 2022

The global market for pediatric healthcare is accounted to approximately $83 billion in 2013 and expected to grow at 7.8% CAGR in future. Increase in demand for chronic disease treatment, Diarrhea and injury related disease is more common in children; however, these diseases vary from short term to long-term treatments that consume a lot time and exert financial pressures on the parents.

Pediatric healthcare is dealing with the treatment of child related diseases, their development and care. Children often suffer from respiratory, gastrointestinal and other chronic disease because of lower immunity. The global market for pediatric healthcare is accounted to approximately $83 billion in 2013 and expected to grow at 7.8% CAGR in future. Increase in demand for chronic disease treatment, Diarrhea and injury related disease is more common in children; however, these diseases vary from short term to long-term treatments that consume a lot time and exert financial pressures on the parents. Changes in child care trend increases the prevalence rate of pediatric diseases. This report provides detail information about current scenario of pediatric treatment and expected growth in it.

Eminent market players include Abbott Laboratories, Gilead Sciences, GlaxosmithklinePlc, Johnson & Johnson, Eli Lilly, AxcanPharma USA, Pfizer, Sanofi, and Wyeth.

KEY BENEFITS

In depth analysis of key drivers, restraints and opportunities of pediatric healthcare market with impact analysis

Porters five forces model provide macro level analysis of market factors that are influencing the growth

Key developmental strategies adopted by top market players engaged in this business to provide better understanding of potential opportunities and challenges in this market

Market estimation for treatment, therapeutics, duration of disease and geographic segment is derived from current market scenario and expected market trends

The report provides for in-depth understanding of the market scenarios in various geographic regions so that key players can make plans to explore opportunities in specific regions

KEY MARKET SEGMENTS

GLOBAL MARKET, BY PERIOD OF DISEASES

  • Long term disease
  • Short term disease

GLOBAL MARKET, BY THERAPEUTICS

  • Asthma and allergies
  • Diabetes,
  • Obesity,
  • Cerebral palsy
  • Chronic illness
  • Others

GLOBAL MARKET, BY TREATMENTS

  • Immunotherapy
  • Dietary Restrictions
  • Medications
  • Surgical Procedures
  • Others

GLOBAL MARKET, BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • ROW

KEY AUDIENCES

  • Pharmaceutical companies engaged in manufacturing, development and commercialization of drugs and surgical equipments
  • Drug dealers and wholesalers
  • Research institutes and facilities
  • Educational and Academics institutes

Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Carl